NCT05369000
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05369000
Title Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Lava Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ESP

Facility Status City State Zip Country Details
UCSF Medical Center at Parnassus San Francisco California 94143 United States Details
M Health Fairview University of Minnesota Medical Center Minneapolis Minnesota 55455 United States Details
Washington University School of Medicine in St. Louis St Louis Missouri 63110 United States Details
NYU Langone Health New York New York 10016 United States Details
Duke University Medical Center - Duke Cancer Center Durham North Carolina 27710 United States Details
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112 United States Details
Radboud Universiteit - Radboud Universitair Medisch Centrum (Radboudumc) Nijmegen Gelderland 6500 HB Netherlands Details
Erasmus MC (Erasmus Universitair Medisch Centrum Rotterdam) Rotterdam South Holland 3000 CA Netherlands Details
Amsterdam UMC - VU Medisch Centrum (VUmc) Amsterdam 1081 HV Netherlands Details
ICO Hospitalet (Hospital Duran i Reynals) Barcelona 08908 Spain Details
Hospital Universitartio 12 De Octubre Madrid 28041 Spain Details
Centro Integral Oncologico Clara Campal (HM CIOCC) Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field